文献速递心外重症与机械循环支持

体外膜氧合期间锁骨下动脉与股动脉插管的倾向匹配比较

Subclavian versus femoral arterial cannulations during extracorporeal membrane oxygenation: A propensity-matched comparison.
PubMed 文献 · J Heart Lung Transplant · 2022-01-10

在法国里尔两家重症监护室2013年1月至2019年12月的372例非濒死成人VA-ECMO患者中,回顾性比较锁骨下动脉插管(52例)与股动脉插管(320例)。倾向匹配后锁骨下插管未减少新发肺水肿或左心室卸载(HR 0.99,95%CI 0.51-1.91),IPTW分析中与恢复减少和严重出血增加相关,并观察到4例意外拔管。作者认为锁骨下插管应限于血管通路问题。

要点

  • 倾向匹配后锁骨下插管未减少新发肺水肿或左心室卸载(HR 0.99,95%CI 0.51-1.91)。
  • IPTW分析中锁骨下插管与恢复减少和严重出血增加相关,观察到4例意外拔管。
  • 作者认为锁骨下动脉插管应限于血管通路问题。

核心结论

  • 锁骨下动脉插管与左心室扩张相关并发症、血栓并发症及28天死亡率降低无关,可能增加严重出血和意外拔管并减少恢复,应限于血管通路问题。

研究设计与样本

  • 本研究为在里尔学术医院两家重症监护室于2013年1月至2019年12月开展的回顾性研究,纳入372例接受VA-ECMO支持的非濒死成人患者。
  • 比较锁骨下动脉插管(52例)与股动脉插管(320例),使用倾向评分匹配(PSM)和逆概率处理加权调整(IPTW)分析结局差异。

主要发现

  • 倾向评分匹配后,与股动脉插管相比,锁骨下插管未减少新发肺水肿或左心室卸载的发生(HR 0.99,95%CI 0.51-1.91)。
  • 倾向评分匹配队列中其他结局无差异。
  • IPTW调整队列中,锁骨下插管与恢复减少和严重出血增加相关,并观察到4例意外拔管。

关键数值与推荐

  • 主要终点为新发肺水肿或左心室卸载。
  • 次要终点包括心肌恢复、严重出血(依据体外生命支持组织定义)、血栓并发症(卒中、插管肢体或肠系膜缺血、心内或主动脉根部血栓)及28天死亡率。

临床怎么用

  • 作者认为锁骨下动脉插管应限于血管通路问题。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During peripheral extracorporeal veno-arterial membrane oxygenation (VA-ECMO) support, subclavian arterial cannulation provides, in comparison to femoral arterial cannulation, an anterograde flow which may prevent from left ventricular (LV) distention and improve outcomes. We aimed to compare the effectiveness of subclavian cannulation to femoral cannulation in reducing LV overdistension consequences, hemostatic complications and mortality. METHODS: This retrospective study conducted in two intensive care units of the Lille academic hospitals from January 2013 to December 2019 included 372 non-moribund adult patients supported by VA-ECMO. The primary endpoint was a new onset of pulmonary edema (PO) or LV unloading. Secondary endpoints were myocardial recovery, serious bleeding (according to Extracorporeal Life Support Organization definition), thrombotic complications (a composite of stroke, cannulated limb or mesenteric ischemia, intracardiac or aortic-root thrombosis) and 28 day mortality. Differences in outcomes were analyzed using propensity score matching (PSM) and inverse probability of treatment weighting adjustment (IPTW). RESULTS: As compared to femoral cannulation (n = 320 patients), subclavian cannulation (n = 52 patients) did not reduce the occurrence of new onset of PO or LV unloading after PSM [HR 0.99 (95% CI 0.51-1.91)]. There was no other difference in outcomes in PSM cohort. In IPTW adjustment cohort, subclavian cannulation was associated with reduced recovery and increased serious bleeding with four accidental decannulations observed. CONCLUSION: Subclavian artery cannulation was not associated with reduced LV distension related complications, thrombotic complications and 28 day mortality. Rather, it may increase serious bleeding and accidental decannulations, and reduce recovery. Therefore, subclavian cannulation should be limited to vascular accessibility issues.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Moussa MD, Rousse N, Abou Arab O, et al. Subclavian versus femoral arterial cannulations during extracorporeal membrane oxygenation: A propensity-matched comparison. J Heart Lung Transplant. 2022. PMID: 35090808. doi:10.1016/j.healun.2022.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。